Morgan Stanley’s GeoVax Labs GOVX Stock Holding History
Bought
Maintained
Sold
Other funds holding GOVX
VFT
TRCT
VCM
SS
DB
Morgan Stanley's GOVX Position: Q2 2026 in Review
Morgan Stanley increased its GeoVax Labs (GOVX) stake by 33,283% in Q2 2026, buying an estimated $3.04K and bringing the position to 2,003 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #7358.
Morgan Stanley first reported a position in GOVX in Q1 2021 and has held it in 22 quarters since. The position peaked at $108K in Q1 2025. 11 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.
- Morgan Stanley held 2,003 shares of GeoVax Labs worth $2.54K as of Q2 2026.
- Morgan Stanley bought 1,997 GeoVax Labs shares in Q2 2026, an estimated $3.04K.
- GeoVax Labs made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7358 holding.
- Morgan Stanley first reported a position in GeoVax Labs in Q1 2021 and has held it in 22 quarters since.
- Morgan Stanley's GeoVax Labs position peaked at $108K in Q1 2025.
- 11 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.